logo
JBA AI Earns FDA SaMD Recognition

JBA AI Earns FDA SaMD Recognition

A New Era of Accessible Health Monitoring
GARDEN GROVE, CALIFORNIA / ACCESS Newswire / June 9, 2025 / JBA AI, the flagship health-tech division under AQ Pharmaceuticals, Inc. and JBA Brands, proudly announces several major global milestones in its mission to make preventive healthcare more accessible, intelligent, and affordable.JBA AI Infographic
JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical Device (SaMD). In addition, the platform has now received Class B Medical Device approval from Vietnam's Ministry of Health. These achievements affirm the platform's safety, clinical effectiveness, and international credibility.
The JBA AI mobile application is already available globally for Android users and will soon be released on iOS. It enables contactless, non-invasive vital signs monitoring directly through smartphones or tablets. In just 60 seconds, the app delivers insights on over nine key health metrics. These include heart rate, heart rate variability, blood oxygen saturation, respiratory rate, stress index, and estimated glucose and blood pressure trends. This is achieved using AI-powered facial signal analysis through camera-based remote photoplethysmography technology.
Expanding its impact even further, JBA AI has partnered with one of Vietnam's largest financial institutions, which serves more than 30 millions members. Together, they are preparing to launch JBA AI nationwide, making preventive health monitoring more accessible through a trusted and widespread digital network.
'JBA AI is more than a health app - it's a certified medical device. Recognized by both the FDA and Vietnam's Ministry of Health,' said Tracy Trang Nguyen, founder and CEO of JBA AI. 'We're proud to deliver trusted, clinically guided tools for daily health monitoring worldwide.'
Nguyen is a Vietnamese American engineer and wellness industry leader who developed JBA AI after surviving cancer. Her personal health journey inspired her to combine advanced artificial intelligence with affordable wellness solutions. Under her leadership, JBA AI complements other products within the JBA Brands portfolio, such as GlucoTrojan, Joint Revive Fucoidan, and Vegan Collagen, to form a fully integrated health ecosystem.
JBA AI is already gaining traction and is starting to expand into pharmacies, corporate wellness programs, public health campaigns, and family clinics across the United States, Vietnam, and other countries. The platform's franchise-ready model supports rapid local deployment while keeping costs low and impact high. It is designed to help people monitor their health in real-time, without the need for needles, wearable devices or clinic visits.
JBA AI is currently welcoming franchisees, affiliates, and institutional partners to help bring this technology to communities around the world. Whether at home or in partnership with healthcare providers, JBA AI is redefining preventive care through data-driven technology and a compassionate approach to well-being.
Contact Information
Catherine Marino
Marketing Manager
[email protected]
(+1) 714 903 1009
SOURCE: AQP One, Inc.
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Astria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE Patients
Astria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE Patients

Yahoo

time26 minutes ago

  • Yahoo

Astria Therapeutics Announces Positive Initial Results from Long-Term Navenibart Trial in HAE Patients

Astria Therapeutics Inc. (NASDAQ:ATXS) is one of the stocks under $10 to buy now. Earlier on June 13, Astria Therapeutics announced positive initial results from the ALPHA-SOLAR long-term open-label trial of navenibart (STAR-0215) in hereditary angioedema/HAE patients. These findings were presented at the European Academy of Allergy and Clinical Immunology/EAACI Annual Congress. The trial showed an overall reduction in the monthly HAE attack rate, with a 92% mean and 97% median reduction. These results support the potential for every three-month and every six-month dosing regimens for navenibart, as well as its favorable safety and tolerability profile. These initial results from ALPHA-SOLAR are consistent with the 'best-in-class' profile observed in the earlier ALPHA-STAR Phase 1b/2 trial. A closeup of pills in a pharmacy, representing the high quality medications of the company. The ALPHA-SOLAR trial is a long-term, open-label study designed to assess the safety and efficacy of navenibart in adults with HAE Type 1 or 2. All 16 target enrollment participants from the Phase 1b/2 ALPHA-STAR trial opted to enroll in ALPHA-SOLAR. Patients from ALPHA-STAR Cohorts 1 and 2 joined Arm A, while Cohort 3 patients joined Arm B. Astria Therapeutics Inc. (NASDAQ:ATXS) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for allergic and immunological diseases in the US. While we acknowledge the potential of ATXS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información

Abeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene Therapy
Abeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene Therapy

Yahoo

time26 minutes ago

  • Yahoo

Abeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene Therapy

Abeona Therapeutics Inc. (NASDAQ:ABEO) is one of the stocks under $10 to buy now. On July 29, AscellaHealth announced its successful HUB partnership with Abeona Therapeutics in the pre- and post-launch commercialization of ZEVASKYN (prademagene zamikeracel), which is an FDA-approved cell-based gene therapy. The collaboration addresses the clinical, operational, and reimbursement needs of this novel autologous cell-based gene therapy by designing and executing patient-centric, end-to-end solutions. An outcome of this partnership was the development and launch of AbeonaAssist, which is a customized patient support program designed to provide a seamless experience for patients, caregivers, and healthcare providers. A close-up of a staff member counting pills in a pharmaceutical warehouse. ZEVASKYN is the first and only autologous cell sheet-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa/RDEB. Abeona Therapeutics Inc. (NASDAQ:ABEO) is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening diseases. While we acknowledge the potential of ABEO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Keen to share your home with a Siamese cat? Find out everything there is to know about this breed
Keen to share your home with a Siamese cat? Find out everything there is to know about this breed

Yahoo

time4 hours ago

  • Yahoo

Keen to share your home with a Siamese cat? Find out everything there is to know about this breed

When you buy through links on our articles, Future and its syndication partners may earn a commission. Siamese cat overview Other names: Meezers Life expectancy: 12–15 years Size: 4–13lbs in weight, 11 inches in height Coat: pointed or colorpoint Eye colour: bright blue eyes Temperament: sociable, affectionate, vocal and intelligent Origin/native country: Thailand Siamese cats aren't hard to come by. Perhaps the most iconic example of this breed is the aptly named Si and Am in Disney's Lady and the Tramp, who are the sinister villains of the show. But in reality, this couldn't be further from the truth. Known for being affectionate, friendly, and sociable, Siamese cats are also loved by the masses for their distinctive narrow-faced look, fur coloring and beautiful blue eyes. This lap cat also has the pretty incredible ability to crave attention no matter the time of the day. Another thing to keep in mind about the Siamese is that they are rather vocal, so they could be ideal for someone who lives alone, or those who much prefer noise and chatter in their home compared to peace and quiet. And its reasons like this (and more) that have earned a 'meezer' the title of being one of the most popular cat breeds. We've compiled a guide on everything there is to know about this Velcro kitty and roped in the expertise of vet Dr Rebecca MacMillan. Are Siamese cats hypoallergenic? All allergy sufferers will be pleased to know that Siamese cats are classified as one of the hypoallergenic cat breeds due to their fur, which sheds a lot less than other breeds and the fact that they produce less of the Fel D1 protein, which can cause allergies in humans to flare up. 'These cats still produce the Fel D 1 protein in their saliva, which gets dispersed through their coat as they groom,' flags Dr MacMillan. Therefore, Siamese cats may still trigger some. But they might be less triggering than other breeds for some allergy sufferers. Are Siamese cats friendly? Despite how they are portrayed in the Disney film, Siamese cats are very friendly cats. They are also very affectionate, too. So if you love lots of love and cuddles from your fur friend, this curious cat, craves companionship and will be more than happy to snuggle up on your lap in the evening as long as they have had enough stimulation during the morning. 'I do have a bit of a soft spot for Siamese cats,' says Dr MacMillan. 'They are friendly, sociable, and enjoy spending time with people. However, they are also known for being vocal and demanding!' So much so, life with a Siamese cat will be anything but quiet as this breed is known for being one of the loudest cat breeds. 'They make great pets if you have time to give them lots of fuss and attention,' Dr MacMillan adds. Wisdom Panel Cat DNA Test | Amazon Not sure exactly what breed your cat is? This kit screens for 70+ breeds, 45 genetic health insights and 25+ physical traits – because knowing every detail about your cat helps you understand how best to care for them. View Deal Siamese cat health issues Siamese are generally healthy and often live to 15 years of age or more. But like many pedigree cats, Siamese are prone to certain health complaints. 'Siamese cats can suffer from asthma, and I have diagnosed a few over the years,' Dr MacMillan says. 'Inflammation of the airways causes breathing issues and wheezing in affected cats.' Amyloidosis is an inherited condition that affects Siamese. 'It causes abnormal proteins to be deposited in various organs around the body,' the veterinarian explains. 'This can cause problems with their ability to function properly. Kidney failure is very common in cats with amyloidosis.' Cancer is often found in this breed. 'No one quite knows for sure why they are more likely to develop it than other cats,' explains Dr MacMillan. 'Lymphoma is a common example and it can affect many areas of the body including the lymph nodes, digestive tract, chest, and kidneys. If detected early enough, it may be treatable with surgery or chemotherapy.' Nystagmus is another condition often seen in Siamese cats. Explaining the health condition, Dr MacMillan says: 'This causes their eyes to flicker slightly from side to side. It doesn't seem to cause them any problems however and their brain is still able to process the visual information okay.' How much exercise do Siamese cats need? As is the case with all cats, Siamese cats will require at least 30 minutes of exercise a day, which can be broken up into small bursts. Of course, pet exercise will look a lot different to human exercise. So while you wouldn't expect your cat to be lifting weights, a Siamese will be more than happy to chase some of the best toys for indoor cats around or play with the best automated cat toys to keep their mind and body engaged. But that said, this clever breed is an active and companionable four-legged feline. So the more engagement and mental stimulation it can get from you, the better. What grooming do Siamese cats need? Siamese cats tend to have short coats so they have minimal grooming needs. However, you will still need to brush them with one of the best cat brushes to keep their coat looking and feeling healthy. This will help to keep their coat glossy and can help get rid of dead fur during shedding seasons, rather than seeing it pile up around your home. It's also important to stay on top of regular nail trims and ear cleaning. How much do Siamese cats cost? Generally speaking, Siamese cats can set you back anywhere between $250 to $2,500. But this will all depend on pedigree, breeder and the area you purchase your Siamese cat from and the rarity of colorations. The higher end of the scale can make a Siamese cat quite expensive. However, if you are lucky enough to adopt a Siamese cat you can expect to pay up to $300. Should I get a Siamese? A Siamese cat is often known as a Velcro cat, as this breed would much rather be in the company of others than its own. This means a Siamese cat will expect a lot of attention and it will make this demand known with its vocal chirping and chatter. Therefore, a Siamese cat might be best for extroverts or loud homes or perhaps someone who lives alone who might favor some companionship in the form of a fur friend. The Complete Guide To Siamese Cats | Amazon Author and experienced Siamese owner Candace Darnforth used interviews with 11 top Siamese breeders to create the perfect guidebook for any new Siamese Deal Read next: Facts about Siamese cats Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store